Please assess the completion status of the following clinical trial:

Trial Title: Identifying and Treating Depression in Hemodialysis Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* currently on hemodialysis at a CDC dialysis unit~* English speaking~* able to provide informed consent~Exclusion Criteria:~* on hemodialysis for less than 3 months~* comorbid psychotic, bipolar, substance use dependence, Alzheimer's or dementia~Not eligible for Phase II (intervention) if currently on antidepressant medication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fluoxetine Group (Type: EXPERIMENTAL): Approximately 96 patients will be enrolled into the intervention (Phase II) over the duration of the entire study.

Based on this trial design, predict the completion outcome and termination type (if applicable).